Harbin Jixianglong Semaglutide Recall
Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 84385-106-06; d) 25g, ND
Updated February 13, 2026
Harbin Jixianglong Biotech is recalling semaglutide powder used for pharmacy compounding due to incomplete process and bacterial endotoxin testing before shipment. Pharmacies may have received untested product.
Is the Harbin Jixianglong Biotech Co., Ltd. recalled? Yes. This product was recalled by FDA on February 13, 2026. Details below.
What is recalled
Semaglutide powder for Rx compounding use only, manufactured by Harbin Jixianglong Biotech Co., Ltd. Sizes and NDC numbers: 1g (NDC 84385-106-01), 5g (NDC 84385-106-02), 10g (NDC 84385-106-06), 25g (NDC 84385-106-03), 50g (NDC 84385-106-04), and 100g (NDC 84385-106-05).
Am I affected
You're affected if your pharmacy received semaglutide powder from Harbin Jixianglong Biotech with the NDC numbers listed above, or if you received a compounded semaglutide medication made from this recalled bulk powder after February 13, 2026.
What to do right now
If you are a pharmacy or healthcare provider, stop dispensing this product immediately and contact your supplier or the FDA. If you received a prescription for compounded semaglutide, contact your pharmacy to confirm whether your medication was made from this recalled powder and follow their guidance.
The hazard
CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
Brands affected
- Source
- FDA
- Category
- Drugs & Medications
- Recall ID
- fda-D-0380-2026
- Classification
- Class II
- Recalled
- February 13, 2026
Get free recall alerts
New Drugs & Medications recalls, the moment they post.
Free forever. Unsubscribe anytime. We never sell your data.
More Drugs & Medications recalls
BD ChloraPrep Hi-Lite Orange Recall
BD ChloraPrep Hi-Lite Orange applicators (a skin antiseptic) were distributed without proper sterilization assurance. These products should have been sterilized …
CareFusion 213, LLC
Methohexital Sodium Injection Recall
Methohexital Sodium for Injection 500 mg multiple dose vials made by OneSource Specialty Pharma have failed quality tests for impurities and degradation. …
ONESOURCE SPECIALTY PHARMA LIMITED
Lacosamide Tablets 100mg Recall
Lacosamide 100mg tablets made by Camber Pharmaceuticals may contain a different medication, Selexipag 1000 mcg, mixed into the bottle. Taking the wrong drug by …
Annora Pharma Private Limited